Glenmark Pharma gets USFDA nod for generic anti-inflammatory drug

Glenmark Pharmaceuticals received USFDA approval for generic Acetaminophen and Ibuprofen tablets. The product, a version of Advil Dual Action, will be distributed by Glenmark Therapeutics Inc, USA. Advil Dual Action achieved annual sales of around USD 84.1 million. Glenmark has 195 products authorized for distribution and 52 ANDAs pending approval.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/fp48DOa
via IFTTT